Wilson Sonsini Goodrich & Rosati represented LENZ in the transaction. Biopharmaceutical company LENZ Therapeutics announced that it raised $83.5 million in an oversubscribed Series B financing....
LENZ Therapeutics’ $83.5 Million Series B Financing
BV Investment Partners’ Investment in Imagenet
Choate represented BV Investment Partners on the deal. BV Investment Partners announced its investment in Imagenet, LLC, a leading provider of back-office support technology and tech-enabled outsourced...
Quad-C Management’s Investment in Synoptek HoldCo
Khaitan & Co. and Gibson, Dunn & Crutcher advised Quad-C Management on the deal, while Choate represented Sverica Capital Management and Synoptek. Synoptek, a leading global...
Droplette’s $15.4 Million Series B Investment Round
Choate represented Victress Capital in the transaction. Droplette, the consumer skincare technology originally developed as a medical device to treat rare and debilitating skin diseases, executed...